- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06719349
Lumbar Discopathy Decompression with Lateral Interbody Fusion: Radiological and Clinical Outcomes
December 3, 2024 updated by: Grzegorz Guzik, Podkarpackie Oncological Center
Single-Level Lateral Lumbar Interbody Fusion in Author's Modification: Clinical and Radiographic Outcomes
The aim of the study was to introduce a single-segment lumbar spine decompression and fusion with intervertebral implants through modified by the authors lateral lumbar approach.
Functional, surgical and radiographic outcomes was evaluated.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
38
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Podkarpackie
-
Brzozów, Podkarpackie, Poland, 38-500
- Subcarpatian Oncology Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
We retrospectively reviewed the medical data of patients who underwent single-level LIF from January to December 2021 at the Orthopaedic Oncology Department in Brzozów and the Trauma and Orthopaedic Department in Stalowa Wola.
Description
Inclusion Criteria:
Single-segment L1-L4 spine discopathy.
Exclusion Criteria:
Any other spinal diseases. More than one level of discopathy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Single level decompression and LLIF
Patients with single-segment L1-L4 spine discopathy treated with lumbar spine fusion modified by the authors were included in this study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the quality of life
Time Frame: 3 months after the surgery
|
the quality of life according to the EQ-VAS - Euro-Quality of Life Visual Analoque Score
|
3 months after the surgery
|
|
the functional status - Karnofsky scale
Time Frame: 3 months after the surgery
|
patients' neurological status, functional status according to the Karnofsky scale
|
3 months after the surgery
|
|
the functional status Oswestry Disability Index
Time Frame: 3 months after the surgery
|
patients' neurological status, functional status according to the ODI - Oswestry Disability Index
|
3 months after the surgery
|
|
the intensity of pain
Time Frame: 3 months after the surgery
|
the intensity of pain according to the VAS - Visual AnalogueScale score
|
3 months after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic Outcomes: The Cross-Sectional Area of the Spinal Canal
Time Frame: 3 months after the surgery
|
Based on pre- and postoperative MRI/RTG the following aspects were assessed: The Cross-Sectional Area of the Spinal Canal, the width and depth of disc extrusion, and the width of the lateral recesses of the spinal canal, anterior disc height lumbar lordosis angle and lumbar segmental angle.
|
3 months after the surgery
|
|
Radiographic Outcomes: The Height and Width of the Intervertebral Foramina
Time Frame: 3 months after the surgery
|
Based on pre- and postoperative MRI/RTG the following aspects were assessed: The Height and Width of the Intervertebral Foramina
|
3 months after the surgery
|
|
Radiographic Outcomes: lumbar segmental angle.
Time Frame: 3 months after the surgery
|
Based on pre- and postoperative MRI/RTG the following aspects were assessed: lumbar segmental angle.
|
3 months after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Schizas C, Theumann N, Burn A, Tansey R, Wardlaw D, Smith FW, Kulik G. Qualitative grading of severity of lumbar spinal stenosis based on the morphology of the dural sac on magnetic resonance images. Spine (Phila Pa 1976). 2010 Oct 1;35(21):1919-24. doi: 10.1097/BRS.0b013e3181d359bd.
- Lin GX, Akbary K, Kotheeranurak V, Quillo-Olvera J, Jo HJ, Yang XW, Mahatthanatrakul A, Kim JS. Clinical and Radiologic Outcomes of Direct Versus Indirect Decompression with Lumbar Interbody Fusion: A Matched-Pair Comparison Analysis. World Neurosurg. 2018 Nov;119:e898-e909. doi: 10.1016/j.wneu.2018.08.003. Epub 2018 Aug 10.
- Ozgur BM, Aryan HE, Pimenta L, Taylor WR. Extreme Lateral Interbody Fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J. 2006 Jul-Aug;6(4):435-43. doi: 10.1016/j.spinee.2005.08.012.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
November 26, 2024
First Submitted That Met QC Criteria
December 3, 2024
First Posted (Estimated)
December 5, 2024
Study Record Updates
Last Update Posted (Estimated)
December 5, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 02-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
The medical records of the patients who participated in the study cannot be shared based on the protection of natural persons with regard to the processing of personal data according to the guidelines of the European Data Protection Board.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spine Degeneration
-
University of Missouri-ColumbiaWithdrawnLumbar Spine Degeneration | Cervical Spine DegenerationUnited States
-
Technical University of MunichNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
3SpineActive, not recruitingLumbar Spine DegenerationUnited States
-
Virtua Health, Inc.Terminated
-
ElsanCompleted
-
Orthofix Inc.CompletedLumbar Spine DegenerationUnited States
-
3SpineMCRAActive, not recruiting
-
Chang Gung Memorial HospitalCompletedCervical Spine DegenerationTaiwan